Neurol. praxi. 2010;11(5):342-346

The present and future of recanalization therapy in acute ischaemic stroke

MUDr.Radek Ampapa
Neurologické oddělení, Nemocnice Jihlava

Intravenous thrombolysis (IVT) is currently a standard effective treatment for acute-stage ischaemic stroke. Because of the limitations

of IVT which include a short therapeutic window and a relatively low efficacy (as assessed by the recanalization of the occluded artery),

new therapeutic methods are investigated. Among the most promising are combined thrombolysis, sonothrombolysis and mechanical

removal, e. g. with the Merci catheter (all of which are being experimentally used at centres in the Czech Republic); moreover, attempts

are made to prolong the time window for treatment with IVT and to more accurately diagnose using imaging methods in acute-stage

stroke (particularly MRI DWI, MRI PWI, CT angiography and perfusion CT). To further prove the true effect on the treatment of ischaemic

stroke, more studies are required; however, their design is complicated by the dominant position of intravenous thrombolysis in early

treatment of acute stroke (it needs to be applied within 4.5 hours of the onset of stroke provided there are no contraindications, except

when occlusion of MCA or BA is confirmed where intra-arterial thrombolysis with a longer therapeutic window is also an option). Furthermore,

it is necessary to demonstrate both recanalization of the occluded artery and the positive effect on the patient's consequent

clinical condition. No therapeutic procedure which would be sufficiently effective, available and safe has been found; however, given

the number of ongoing trials with promising early results, the future certainly is hopeful.

Keywords: thrombolysis, acute cerebral infarction, Merci catheter, sonothrombolysis

Published: December 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ampapa R. The present and future of recanalization therapy in acute ischaemic stroke. Neurol. praxi. 2010;11(5):342-346.
Download citation

References

  1. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic Resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution - (DEFUSE) study. Ann Neurol. 2006; 60(5): 508-517. Go to original source... Go to PubMed...
  2. Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC. Clotbust Investigators. Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. Neuroimaging 2004; 14(2): 113-117. Go to original source... Go to PubMed...
  3. Combined intravenous and intraarterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. The IMS Study Investigators. Stroke; 2004; 35(4): 904-911.
  4. Dubinsky R, Lai S-M. Mortality of stroke patients treated with thrombolysis: Analysis of nationwide inpatent sample. Neurology 2006; 66: 1742-1744. Go to original source... Go to PubMed...
  5. Eggers J, Seidel G, Koch B, König IR. Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA. Neurology 2005; 22: 1052-1054. Go to original source... Go to PubMed...
  6. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS). Stroke; 2005; 36(1): 66-73. Go to original source... Go to PubMed...
  7. Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006; 5(8): 661-667. Go to original source... Go to PubMed...
  8. Martini SR, Hill MD, Alexandrov AV, Molina CA, Kent TA. Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy. Neurology 2006; 67: 700-702. Go to original source... Go to PubMed...
  9. Rohan V, Ševčík P, Polívka J, Ambler Z, Kreuzberg B, Ferda J. Klinický pohled na výpočetní tomografii u akutní ischémie mozku. Cesk Slov Neurol N 2007; 70/103(6): 643-652.
  10. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke; 2008; 39(4): 1205-1212. Go to original source... Go to PubMed...
  11. Školoudík D, Bar M, Škoda O, Václavík D, Hradílek P, Langová K, Herzig R, Kaňovský P. Účinnost sonotrombotripse a sonotrombolýzy v rekanalizaci střední mozkové tepny. Cesk Slov Neurol N 2007; 70/103(3): 248-252.
  12. Školoudík D, Fadrná T, Bar M, Zapletalová O, Zapletal O, Blatný J, Langová K, Šaňák D, Král M, Herzig R, Kaňovský P. Ovlivnění fibrinolytického systému pomocí kontinuálního dopplerovského monitoringu u zdravých dobrovolníků. Cesk Slov Neurol N 2009; 72/105(5): 446-452.
  13. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25(5): 457-507. Go to original source... Go to PubMed...
  14. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurogical Disorders and Stroke rt-PA Stroke Study Group. N Engl. J Med 1995; 333(24): 1581-1587.
  15. Update Guidelines January 2009 New Elements. Available from: URL: http://www.eso-stroke.org/pdf/ESO_Extended_Thrombolysis_KSU.pdf.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.